NCT01896531 2022-03-02A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction CancerGenentech, Inc.Phase 2 Completed153 enrolled 16 charts